How Tech Billionaires Are Disrupting Biomedical Science
Money from the world’s increasingly prosperous technology entrepreneurs has been flooding into biomedical research. Is it changing how science is done?
web articles
Send us a link
Money from the world’s increasingly prosperous technology entrepreneurs has been flooding into biomedical research. Is it changing how science is done?
What does it cost to uphold research integrity in scholarly publishing?
Algorithm looks for clues about a paper's origin that text-based detectors miss.
Artificial-intelligence systems can generate hypotheses, design experiments and analyse data - but humans still need to decide what makes sense.
The latest Scholars at Risk Free to Think report shows academic freedom continues to be under increasing attack in many countries. But erosion of academic freedom could be reversed by new governments.
In Switzerland, science enjoys greater public trust than the police, government or parliament. But what exactly is the role of science in a democracy, and how does it differ in dictatorships?
The German National Academy of Sciences Leopoldina has signed the position paper Free Science – Successful Economy – Strong Germany, published today by the Berlin Research Network.
Government report shows “challenges with academic engagement”.
A rapidly increasing number of published articles rely on analyses produced via the TriNetX platform. However, TriNetX users don’t get full access to the information in the platform, muddying the truthfulness of any analyses of the data and compromising the integrity statements offered by authors and accepted by journals.
If reviewers can't reliably tell the difference between top grant proposals, why should they pretend they can? A new wave of funders is turning to lotteries to break the tie.
Has quantum advantage been achieved, and what does this mean for scientists?
In contested and cautious times, cross-sector working is needed to push EDI work forward. What can this look like in the context of research funding? In contested and cautious times, cross-sector working is needed to push EDI work forward.
As conflicts escalate, resource shortages and patient safety force researchers in Middle Eastern countries to make difficult decisions about clinical trials.
A cutting-edge gene-editing trial in China went disastrously wrong. A family wants accountability.
A brief outage at NCBI, the US government’s biomedical database, exposed the risks of relying on a single repository and renewed calls for a global, decentralized data-sharing network.
Project Hail Mary, Jurassic Park: from dino-mosquitoes to a spaceship’s roar, pointless mistakes on the scientific details make me wince.